| 000 | 01546 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515041742.0 | ||
| 264 | 0 | _c20070309 | |
| 008 | 200703s 0 0 eng d | ||
| 022 | _a8756-3282 | ||
| 024 | 7 |
_a10.1016/j.bone.2006.07.027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElston, Marianne S | |
| 245 | 0 | 0 |
_aA case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery. _h[electronic resource] |
| 260 |
_bBone _cJan 2007 |
||
| 300 |
_a236-41 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xanalysis |
| 650 | 0 | 4 |
_aBone and Bones _xdiagnostic imaging |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFibroblast Growth Factor-23 |
| 650 | 0 | 4 |
_aFibroblast Growth Factors _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperparathyroidism _xdrug therapy |
| 650 | 0 | 4 |
_aOctreotide _xtherapeutic use |
| 650 | 0 | 4 |
_aOsteomalacia _xcomplications |
| 650 | 0 | 4 |
_aPhosphates _xblood |
| 650 | 0 | 4 | _aTomography, X-Ray Computed |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVitamin D _xanalogs & derivatives |
| 700 | 1 | _aStewart, Inge J | |
| 700 | 1 | _aClifton-Bligh, Roderick | |
| 700 | 1 | _aConaglen, John V | |
| 773 | 0 |
_tBone _gvol. 40 _gno. 1 _gp. 236-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bone.2006.07.027 _zAvailable from publisher's website |
| 999 |
_c16561246 _d16561246 |
||